SCHEMBL23818965

SCHEMBL23818965

COC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OC)OC[C@@]1(C)O[C@@H](c2ccc3c(NC(C)=O)ncnn23)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23819061 0.90 BTN3A1 (0.40) —
SCHEMBL26331349 0.90 TMPRSS2 (0.33) —
SCHEMBL23818693 0.89 — —
SCHEMBL26344794 0.86 — —
SCHEMBL23819056 0.84 POLRMT (0.38) —
SCHEMBL26333935 0.83 POLRMT (0.38) —
SCHEMBL23818950 0.83 — —
SCHEMBL23818833 0.82 POLRMT (0.38) —
SCHEMBL26344755 0.81 — —
SCHEMBL26331348 0.80 BTN3A1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback